{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T17:01:56Z","timestamp":1764349316422},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Department of Sichuan Province, China","award":["2021YFS0078"],"award-info":[{"award-number":["2021YFS0078"]}]},{"name":"Cadre Health Care Committee of Sichuan Province","award":["2019-1701"],"award-info":[{"award-number":["2019-1701"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pregnancy complicated with endometrial atypical hyperplasia, which is often observed during early pregnancy, is extremely rare.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The patient was a 30-year-old woman who had premature delivery at 30<jats:sup>+\u20091<\/jats:sup> weeks gestation, and endometrial atypical hyperplasia was discovered by placental examination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>For patients who undergo fertility-sparing treatment for endometrial atypical hyperplasia, the evaluation of the decidua via the placental pathological examination is particularly important. These examinations make a great clinical contribution to the early detection and diagnosis of endometrial atypical hyperplasia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-023-05972-0","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T08:02:14Z","timestamp":1695628934000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrent endometrial atypical hyperplasia diagnosed by pathological examination of the placenta from a live birth: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Weilu","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"key":"5972_CR1","unstructured":"Board E, Tumours, WCo. WHO Classification of Tumours Female Genital Tumours. 5th ed2020."},{"key":"5972_CR2","unstructured":"Nadeem R, Catheryn M. National Comprehensive Cancer Network Guidelines Version 2.2023 Uterine Neplasms."},{"issue":"12","key":"5972_CR3","first-page":"1789","volume":"41","author":"MH Auclair","year":"2019","unstructured":"Auclair MH, Yong PJ, Salvador S, Thurston J, Colgan TTJ, Sebastianelli A. Guideline No. 390-Classification and management of endometrial hyperplasia. Journal of obstetrics and gynaecology Canada: JOGC = Journal d\u2019obstetrique et gynecologie du Canada. : JOGC. 2019;41(12):1789\u2013800.","journal-title":": JOGC"},{"issue":"4","key":"5972_CR4","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.ejca.2012.09.017","volume":"49","author":"JY Park","year":"2013","unstructured":"Park JY, Kim DY, Kim JH, Kim YM, Kim KR, Kim YT, et al. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). Eur J cancer (Oxford England: 1990). 2013;49(4):868\u201374.","journal-title":"Eur J cancer (Oxford England: 1990)"},{"issue":"1","key":"5972_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijgo.2015.06.046","volume":"132","author":"M Chen","year":"2016","unstructured":"Chen M, Jin Y, Li Y, Bi Y, Shan Y, Pan L. Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer. Int J Gynaecol Obstet. 2016;132(1):34\u20138.","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"5972_CR6","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/IGC.0b013e3181aae1fb","volume":"19","author":"HS Hahn","year":"2009","unstructured":"Hahn HS, Yoon SG, Hong JS, Hong SR, Park SJ, Lim JY, et al. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer. Int J Gynecol cancer: Official J Int Gynecol Cancer Soc. 2009;19(6):1068\u201373.","journal-title":"Int J Gynecol cancer: Official J Int Gynecol Cancer Soc"},{"issue":"4","key":"5972_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/IGC.0000000000000098","volume":"24","author":"CJ Wang","year":"2014","unstructured":"Wang CJ, Chao A, Yang LY, Hsueh S, Huang YT, Chou HH, et al. Fertility-preserving treatment in young women with endometrial adenocarcinoma: a long-term cohort study. Int J Gynecol cancer: Official J Int Gynecol Cancer Soc. 2014;24(4):718\u201328.","journal-title":"Int J Gynecol cancer: Official J Int Gynecol Cancer Soc"},{"issue":"1","key":"5972_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00404-014-3417-z","volume":"291","author":"C Ohyagi-Hara","year":"2015","unstructured":"Ohyagi-Hara C, Sawada K, Aki I, Mabuchi S, Kobayashi E, Ueda Y, et al. Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature. Arch Gynecol Obstet. 2015;291(1):151\u20137.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"5972_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ygyno.2015.10.015","volume":"139","author":"YF Yang","year":"2015","unstructured":"Yang YF, Liao YY, Liu XL, Su SG, Li LZ, Peng NF. Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatment. Gynecol Oncol. 2015;139(3):419\u201323.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"5972_CR10","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1097\/IGC.0000000000001008","volume":"27","author":"H Zhou","year":"2017","unstructured":"Zhou H, Cao D, Yang J, Shen K, Lang J. Gonadotropin-releasing hormone agonist combined with a levonorgestrel-releasing Intrauterine System or Letrozole for fertility-preserving treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women. Int J Gynecol cancer: Official J Int Gynecol Cancer Soc. 2017;27(6):1178\u201382.","journal-title":"Int J Gynecol cancer: Official J Int Gynecol Cancer Soc"},{"issue":"6","key":"5972_CR11","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1097\/IGC.0000000000000467","volume":"25","author":"SM Pronin","year":"2015","unstructured":"Pronin SM, Novikova OV, Andreeva JY, Novikova EG. Fertility-sparing treatment of early endometrial Cancer and complex atypical hyperplasia in Young Women of Childbearing potential. Int J Gynecol cancer: Official J Int Gynecol Cancer Soc. 2015;25(6):1010\u20134.","journal-title":"Int J Gynecol cancer: Official J Int Gynecol Cancer Soc"},{"issue":"7","key":"5972_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3109\/09513590.2011.649813","volume":"28","author":"AI Pashov","year":"2012","unstructured":"Pashov AI, Tskhay VB, Ionouchene SV. The combined GnRH-agonist and intrauterine levonorgestrel-releasing system treatment of complicated atypical hyperplasia and endometrial cancer: a pilot study. Gynecol Endocrinology: Official J Int Soc Gynecol Endocrinol. 2012;28(7):559\u201361.","journal-title":"Gynecol Endocrinology: Official J Int Soc Gynecol Endocrinol"},{"issue":"4","key":"5972_CR13","doi-asserted-by":"publisher","first-page":"358e1","DOI":"10.1016\/j.ajog.2013.06.031","volume":"209","author":"MK Kim","year":"2013","unstructured":"Kim MK, Seong SJ, Kim YS, Song T, Kim ML, Yoon BS, et al. Combined medroxyprogesterone acetate\/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer. Am J Obstet Gynecol. 2013;209(4):358e1\u20134.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"5972_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1471-0528.2010.02552.x","volume":"117","author":"TJ Cade","year":"2010","unstructured":"Cade TJ, Quinn MA, Rome RM, Neesham D. Progestogen treatment options for early endometrial cancer. BJOG: An International Journal of Obstetrics and Gynaecology. 2010;117(7):879\u201384.","journal-title":"BJOG: An International Journal of Obstetrics and Gynaecology"},{"issue":"4","key":"5972_CR15","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.3802\/jgo.2019.30.e61","volume":"30","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Huang H, Feng F, Wang J, Cheng N. A pilot study of gonadotropin-releasing hormone agonist combined with aromatase inhibitor as fertility-sparing treatment in obese patients with endometrial cancer. J Gynecologic Oncol. 2019;30(4):e61.","journal-title":"J Gynecologic Oncol"},{"key":"5972_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejogrb.2022.04.019","volume":"273","author":"S De Rocco","year":"2022","unstructured":"De Rocco S, Buca D, Oronzii L, Petrillo M, Fanfani F, Nappi L, et al. Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2022;273:90\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"11","key":"5972_CR17","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1136\/ijgc-2020-001309","volume":"30","author":"E Baxter","year":"2020","unstructured":"Baxter E, Brennan DJ, McAlpine JN, Mueller JJ, Amant F, van Gent M, et al. Improving response to progestin treatment of low-grade endometrial cancer. Int J Gynecol cancer: Official J Int Gynecol Cancer Soc. 2020;30(11):1811\u201323.","journal-title":"Int J Gynecol cancer: Official J Int Gynecol Cancer Soc"},{"key":"5972_CR18","doi-asserted-by":"crossref","unstructured":"Rodolakis A, Scambia G, Planchamp F, Acien M, Di Spiezio Sardo A, Farrugia M, Grynberg M, Pakiz M, Pavlakis K, Vermeulen N, Zannoni G, Zapardiel I, Macklon KLT. ESGO\/ESHRE\/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma. Hum Reprod Open. 2023;2023(1).","DOI":"10.1093\/hropen\/hoac057"},{"key":"5972_CR19","unstructured":"ChenXiaojun et al. YangJiaxin,WangHuaying,YuQi,LuoXuezhen,XueHuadan,. Consensus on fertility preservation treatment for early stage endometrial cancer and atypical hyperplasia. Chinese Journal of Obstetrics and Gynecology.2019;54(2):80\u201380."},{"issue":"7","key":"5972_CR20","first-page":"5","volume":"14","author":"G Wang","year":"2022","unstructured":"Wang G. Chen Jie,Deng Kaixian,Chen Qionghua.Expert recommendations for the long-term management of endometrial proliferative disorders. Chin J Family Plann Gynecotokology. 2022;14(7):5.","journal-title":"Chin J Family Plann Gynecotokology"},{"issue":"4","key":"5972_CR21","first-page":"346","volume":"43","author":"Chinese Expert Consensus Compilation Group for Multiple","year":"2023","unstructured":"Chinese Expert Consensus Compilation Group for Multiple. Disciplinary treatment in Endometrial Cancer Desiring Fertility preserving Treatment.Chinese expert consensus on multiple disciplinary treatment in endometrial cancer desiring fertility preserving treatment. Chin J Reprod Contracept. 2023;43(4):346\u201356.","journal-title":"Chin J Reprod Contracept"},{"key":"5972_CR22","unstructured":"Mingzhu L, Zhiqi W, LIjun Z, Xiaoping L, Jianliu W, chunfang Z et al. Analysis of the influencing factors of recurrence and prognosis in patients with stage I to II endometrial cancer. Chin J Obstet Gynecol. 2014."},{"issue":"9612","key":"5972_CR23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (London England). 2008;371(9612):569\u201378.","journal-title":"Lancet (London England)"},{"issue":"1","key":"5972_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ygyno.2004.06.045","volume":"95","author":"PT Ramirez","year":"2004","unstructured":"Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004;95(1):133\u20138.","journal-title":"Gynecol Oncol"},{"key":"5972_CR25","unstructured":"Zhiqi W, Jianliu W, Lihui W. Clinical observation of adjuvant endocrine therapy for stage I endometrial cancer. 2006;22(11):4."},{"issue":"1","key":"5972_CR26","first-page":"21","volume":"55","author":"YJ He","year":"2020","unstructured":"He YJ, Wang YQ, Tang HR, He M, Rao Y, Zhou R, et al. [Clinical efficacy and pregnancy outcomes of fertility-preserving re-treatment after recurrence of the patient with atypical endometrial hyperplasia and early stage endometrial carcinoma]. Zhonghua fu chan ke za zhi. 2020;55(1):21\u20138.","journal-title":"Zhonghua fu chan ke za zhi"},{"issue":"1","key":"5972_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ygyno.2012.12.037","volume":"129","author":"JY Park","year":"2013","unstructured":"Park JY, Lee SH, Seong SJ, Kim DY, Kim TJ, Kim JW, et al. Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin. Gynecol Oncol. 2013;129(1):7\u201311.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"5972_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12884-019-2489-y","volume":"19","author":"M Shiomi","year":"2019","unstructured":"Shiomi M, Matsuzaki S, Kobayashi E, Hara T, Nakagawa S, Takiuchi T, et al. Endometrial carcinoma in a gravid uterus: a case report and literature review. BMC Pregnancy Childbirth. 2019;19(1):425.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"5972_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3892\/mco.2021.2457","volume":"16","author":"T Maeda","year":"2022","unstructured":"Maeda T, Nishimura M, Sogawa E, Kaji T, Irahara M, Iwasa T. Pathological examination of a placenta leading to the diagnosis of endometrial carcinoma: a case report. Mol Clin Oncol. 2022;16(1):24.","journal-title":"Mol Clin Oncol"},{"issue":"7","key":"5972_CR30","doi-asserted-by":"publisher","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","volume":"140","author":"TY Khong","year":"2016","unstructured":"Khong TY, Mooney EE, Ariel I, Balmus NC, Boyd TK, Brundler MA, et al. Sampling and definitions of placental lesions: amsterdam placental workshop Group Consensus Statement. Arch Pathol Lab Med. 2016;140(7):698\u2013713.","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"5972_CR31","first-page":"692","volume":"57","author":"YQ Wang","year":"2022","unstructured":"Wang YQ, Kang N, Li LW, Wang ZQ, Zhou R, Shen DH, et al. [Significance of molecular classification in fertility-sparing treatment of endometrial carcinoma and atypical endometrial hyperplasia]. Zhonghua fu chan ke za zhi. 2022;57(9):692\u2013700.","journal-title":"Zhonghua fu chan ke za zhi"},{"key":"5972_CR32","doi-asserted-by":"publisher","first-page":"948509","DOI":"10.3389\/fmed.2022.948509","volume":"9","author":"U Catena","year":"2022","unstructured":"Catena U, Della Corte L, Raffone A, Travaglino A, Lucci Cordisco E, Teodorico E, et al. Fertility-sparing treatment for endometrial cancer and atypical endometrial hyperplasia in patients with Lynch Syndrome: molecular diagnosis after immunohistochemistry of MMR proteins. Front Med. 2022;9:948509.","journal-title":"Front Med"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-05972-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-023-05972-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-05972-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:23:15Z","timestamp":1700490195000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-023-05972-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5972"],"URL":"https:\/\/doi.org\/10.1186\/s12884-023-05972-0","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]},"assertion":[{"value":"7 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work has been carried out in accordance with the Declaration of Helsinki (2000) of the World Medical Association, this study was approved by the ethics committee of hospital, and informed consent of the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"691"}}